Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-16
DOI
10.1186/s13045-020-00906-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic alterations and their clinical implications in DLBCL
- (2019) Yi Miao et al. Nature Reviews Clinical Oncology
- Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
- (2019) Bhawana George et al. Journal of Hematology & Oncology
- Emerging Insights Into the Role of the Hippo Pathway in Multiple Myeloma and Associated Bone Disease
- (2019) Anastasios Kyriazoglou et al. Clinical Lymphoma Myeloma & Leukemia
- m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
- (2019) Dan Jin et al. Journal of Hematology & Oncology
- Genetics of diffuse large B-cell lymphoma
- (2018) Laura Pasqualucci et al. BLOOD
- Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
- (2018) Hong Zhu et al. CANCER RESEARCH
- Regulation of the Hippo pathway in cancer biology
- (2018) Sungho Moon et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
- (2018) Reham Abdel-Wahab et al. Journal of Hematology & Oncology
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma
- (2018) James D. Phelan et al. NATURE
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia
- (2018) Ya Zhang et al. ONCOGENE
- The Hippo pathway in normal development and cancer
- (2018) Marcello Maugeri-Saccà et al. PHARMACOLOGY & THERAPEUTICS
- The Hippo Signaling Network and its Biological Functions
- (2018) Jyoti R. Misra et al. Annual Review of Genetics
- EGF Receptor–Dependent YAP Activation Is Important for Renal Recovery from AKI
- (2018) Jianchun Chen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
- (2018) Iván M. Moya et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer
- (2017) Hsiang-Hsi Ling et al. EXPERIMENTAL CELL RESEARCH
- Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma
- (2017) Xiangxiang Zhou et al. Journal of Hematology & Oncology
- Klotho suppresses tumor progression via inhibiting IGF-1R signaling in T-cell lymphoma
- (2017) Xiangxiang Zhou et al. ONCOLOGY REPORTS
- Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia
- (2017) Anna Chorzalska et al. STEM CELLS AND DEVELOPMENT
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity
- (2016) Haiwen Chen et al. EXPERIMENTAL CELL RESEARCH
- Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo
- (2016) Hui Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
- (2015) Kang Lu et al. CANCER LETTERS
- Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor
- (2015) A. Sebio et al. CLINICAL CANCER RESEARCH
- The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
- (2015) Chunbo He et al. EMBO Molecular Medicine
- β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis
- (2015) Jing Cai et al. GENES & DEVELOPMENT
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
- (2015) E Ciamporcero et al. ONCOGENE
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
- (2014) S. Song et al. CANCER RESEARCH
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
- (2014) Francesca Cottini et al. NATURE MEDICINE
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
- (2012) Fa-Xing Yu et al. CELL
- Evaluation of verteporfin pharmakokinetics – redefining the need of photosensitizers in ophthalmology
- (2012) Focke Ziemssen et al. Expert Opinion on Drug Metabolism & Toxicology
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- (2011) J. W. Friedberg Hematology-American Society of Hematology Education Program
- YAP is a candidate oncogene for esophageal squamous cell carcinoma
- (2010) Tomoki Muramatsu et al. CARCINOGENESIS
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now